TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Ocumension Therapeutics ( (HK:1477) ) has provided an update.
Ocumension Therapeutics has updated the terms of reference for its Nomination Committee, which is responsible for identifying and recommending candidates for the company’s board of directors. This move is part of the company’s efforts to ensure compliance with applicable laws and listing standards, and to enhance the governance process by including a diverse and independent board composition.
The most recent analyst rating on (HK:1477) stock is a Buy with a HK$7.29 price target. To see the full list of analyst forecasts on Ocumension Therapeutics stock, see the HK:1477 Stock Forecast page.
More about Ocumension Therapeutics
Ocumension Therapeutics is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry with a focus on developing and commercializing ophthalmic therapies.
Average Trading Volume: 7,170,339
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.57B
See more data about 1477 stock on TipRanks’ Stock Analysis page.